Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The embryo implantation process is a highly regulated, multi-phase event in which a blastocyst (early embryo) attaches to and invades the uterine endometrium, initiating pregnancy[1][2][4][5]. This process requires synchronized preparation of both embryo and endometrium, largely under the control of ovarian steroid hormones (estrogen and progesterone) and entails tightly regulated paracrine, autocrine, and juxtacrine molecular interactions[1][4][6]. Key phases include apposition, adhesion, and invasion of the endometrial lining by trophoblast cells. Multiple molecular mediators—such as steroid hormones, growth factors (e.g., HB-EGF), cytokines, adhesion molecules (e.g., L-selectin), and changes in endometrial gene/protein expression—govern this process[1][3][4][6]. The outcome is formation of the decidualized uterine tissue and subsequent placentation to support embryonic development[6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Embryo implantation process.